ask="N/A"
ask_size="N/A"
average_daily_volume="1575890"
bid="7.05"
bid_size="1000"
book_value="0.02"
change="-0.04"
change_from_200_day_moving_average="2.38"
change_from_50_day_moving_average="1.54"
change_from_52_week_high="-0.20"
change_From_52_week_low="5.40"
change_in_percent="-0.51%"
close="7.76"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.75"
ebitda="-48.12M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.66"
ex_dividend_date="N/A"
float_shares="50464000"
high="7.87"
high_52_weeks="7.96"
last_trade_date="3/7/2017"
last_trade_price="7.76"
last_trade_size="64340"
last_trade_time="4:00pm"
low="7.33"
low_52_weeks="2.36"
market_capitalization="573.89M"
moving_average_200_day="5.38"
moving_average_50_day="6.22"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.78"
open="7.70"
pe_ratio="N/A"
peg_ratio="-0.58"
percent_change_from_200_day_moving_average="+44.15%"
percent_change_from_50_day_moving_average="+24.79%"
percent_change_from_52_week_high="-2.51%"
percent_change_from_52_week_low="+228.81%"
previous_close="7.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="371.43"
price_per_sales="21.89"
revenue="26.35M"
shares_outstanding="73955000"
short_ratio="10.66"
stock_exchange="NMS"
symbol="BCRX"
volume="1700491"
weeks_range_52="2.36 - 7.96"
